Full Press Release Details
MINNEAPOLIS,Jan. 20, 2026/PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call and webcast on Wednesday, February 4, 2026, at 8:00 a.m. CST to review its second quarter fiscal 2026 financial results.
Access to the discussion may be obtained as follows:
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 11160826.
The replay will be available from 11:00 a.m. CST on Wednesday, February 4, 2026, until 11:00 p.m. CST on Wednesday, March 4, 2026.
About Bio-TechneBio-Techne Corporation (NASDAQ:TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visithttps://www.bio-techne.comor follow the Company on social media atLinkedIn,X, orYouTube.
| Time: | 8:00 a.m. CST |
| Date: | February 4, 2026 |
| Dial-in: | 1-800-579-2543 or 1-785-424-1789 (for international callers) |
| Conference ID: | TECHQ2 |
| Webcast: | https://investors.bio-techne.com/ir-calendar |
| Contact: | David Clair, Vice President, Investor Relations |
| [email protected] | |
| 612-656-4416 |